Repository logo
  • English
  • 中文
Log In
Have you forgotten your password?
  1. Home
  2. College of Medicine / 醫學院
  3. Oncology / 腫瘤醫學研究所
  4. First-line systemic treatment of advanced stage non-small-cell lung cancer in Asia: consensus statement from the Asian Oncology Summit 2009
 
  • Details

First-line systemic treatment of advanced stage non-small-cell lung cancer in Asia: consensus statement from the Asian Oncology Summit 2009

Journal
The Lancet Oncology
Journal Volume
10
Journal Issue
11
Pages
1102-1110
Date Issued
2009
Author(s)
Soo R.A
Anderson B.O
Cho B.C
CHIH-HSIN YANG  
Liao M
Lim W.-T
Goldstraw P
Mok T.S.
DOI
10.1016/S1470-2045(09)70238-4
URI
https://www.scopus.com/inward/record.uri?eid=2-s2.0-71549117595&doi=10.1016%2fS1470-2045%2809%2970238-4&partnerID=40&md5=3f27c5324a4d558230a05409a73c3f6d
https://scholars.lib.ntu.edu.tw/handle/123456789/495108
Abstract
Non-small-cell lung cancer (NSCLC) is an increasing global challenge, especially in low-income countries. Most guidelines for the management of advanced-stage NSCLC have limited effect in countries with resource constraints. Following a systematic literature search, we present an overview of the management of advanced-stage NSCLC in the first-line setting, discuss resources required for systemic therapy, and provide treatment recommendations stratified to four resources levels. Treatment guidelines appropriate for different resource levels offer a realistic approach to management of advanced-stage NSCLC, by recognising the limitations of a particular health-care system. Although there are many barriers to cancer control in low-resource countries, these can be overcome by using measures that are culturally appropriate, economically feasible, and evidence-based. Initiatives include strategic planning, tobacco control, training of health-care workers, access to therapeutic agents, acquisition of information, public education, and alliances with established institutions and international organisations. ? 2009 Elsevier Ltd. All rights reserved.
SDGs

[SDGs]SDG3

Other Subjects
bevacizumab; carboplatin; cetuximab; cisplatin; docetaxel; erlotinib; etoposide; gefitinib; gemcitabine; ifosfamide; irinotecan; mitomycin; navelbine; paclitaxel; pemetrexed; placebo; taxane derivative; teniposide; vinblastine; Vinca alkaloid; vindesine; advanced cancer; Asia; cancer survival; clinical trial; drug megadose; drug protein binding; drug response; elderly care; health care system; health program; human; low drug dose; lung non small cell cancer; maintenance therapy; multiple cycle treatment; nephrotoxicity; practice guideline; primary health care; priority journal; resource allocation; review; thrombocytopenia; treatment duration; vomiting; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asia; Carcinoma, Non-Small-Cell Lung; Congresses as Topic; Cost-Benefit Analysis; Developing Countries; Drug Costs; Evidence-Based Medicine; Guideline Adherence; Health Care Costs; Health Services Accessibility; Healthcare Disparities; Humans; Lung Neoplasms; Medical Oncology; Neoplasm Staging; Treatment Outcome
Publisher
Lancet Publishing Group
Type
Review

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Open policy finder網站查詢,以確認出版單位之版權政策。
    Please use Open policy finder to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science